Perrigo’s New Papa: CEO Brings Product Development Know-How To Post
This article was originally published in The Tan Sheet
Executive Summary
Joseph Papa brings 30 years of experience in healthcare and specialty generic pharmaceutical industries to his new position as president and CEO of Perrigo, the private-label manufacturer announced Sept. 11
You may also be interested in...
Perrigo Makes Softgel Move As Mylan Continues Takeover Play
Acquiring Patheon’s Mexico plant not only adds softgel capabilities to Perrigo’s operations but also boosts its value as an acquisition target. The firm continues integrating Omega Pharma’s operations and managing its OTC private label and other businesses as Mylan presses for Perrigo shareholders to consider its bid.
Perrigo Makes Softgel Move As Mylan Continues Takeover Play
Acquiring Patheon’s Mexico plant not only adds softgel capabilities to Perrigo’s operations but also boosts its value as an acquisition target. The firm continues integrating Omega Pharma’s operations and managing its OTC private label and other businesses as Mylan presses for Perrigo shareholders to consider its bid.
Perrigo Builds Sales On Smoking Cessation, Eyes Prilosec OTC In 2007
Pursuit of private-label omeprazole for a possible 2007 launch fits Perrigo's ongoing strategy of focusing on new products to drive sales growth